Mammo

Imagion Biosystems and Siemens Healthineers Extend Collaboration

Imagion Biosystems has extended its collaboration with Siemens Healthineers to support the Phase 2 clinical trial of the MagSense imaging agent for HER2-positive breast cancer.

AI Mammogram Risk Scores May Improve Long-Term Breast Cancer Risk Assessment

Researchers have found that AI-derived breast cancer risk scores from screening mammograms change over time in women who develop breast cancer while remaining stable in cancer-free women.

Siemens Healthineers Expands Contrast-Enhanced Mammography and Biopsy Capabilities

Siemens Healthineers has expanded the contrast-enhanced mammography and biopsy capabilities of its MAMMOMAT B.brilliant system with a new image-reconstruction technique designed to support diagnostics in dense breast tissue.

Gnosis for Her Launches Mobile 3D Breast CT Care Unit

Gnosis for Her has unveiled a mobile breast care unit featuring an FDA-cleared 3D breast CT system that provides high-resolution imaging without compression, improving comfort and accessibility for women’s breast diagnostics.

Calidar Reports First 4D Mammography Imaging System

Calidar has reported the first patient imaging with its investigational 4D Mammography system.

RSNA AI Challenge Models Interprets Mammography Screening

AI models developed during the RSNA Screening Mammography Breast Cancer Detection Challenge showed strong performance in breast cancer detection.

FDA Grants Breakthrough Status to AI Breast Cancer Risk Tool

A new AI-powered software analyzes mammograms to predict a woman's personalized five-year risk of developing breast cancer, earning the FDA’s Breakthrough Device designation.

RadNet and iCAD Unite to Revolutionize AI-Driven Breast Cancer Detection

Strategic Alliance to Enhance Early Detection and Global Access through AI

Putting Patients First Beyond the Scan: Bayer at ECR 2025

Nelson Ambrogio and Peter Seidensticker from Bayer Radiology highlighted the crucial role of informed patients in improving healthcare outcomes at the ECR 2025.

Breast cancer diagnostics: technical possibilities are not yet being used sufficiently

Advancements and Challenges in Breast Cancer Diagnostics